|
|
SciBase announces final outcome of the rights issue and the resolution on a set-off issue within the framework of the offer to repurchase outstanding warrants of series TO 2 |
|
|
Change of date for publication of the year-end report for the financial year 2025 |
|
|
Increased commitment in SciBase rights issue |
|
|
SciBase publishes information document regarding rights issue |
|
|
SciBase announces outcome of the offer to repurchase outstanding warrants of series TO 2 |
|
|
The Board of Directors of SciBase resolves on a previously communicated rights issue of shares of approximately SEK 83 million |
|
|
SciBase Expands Its Intellectual Property Portfolio to include the analysis of the epithelial skin barrier with New European Patent |
|
|
SciBase publishes information document regarding the offer to repurchase outstanding warrants of series TO 2 |
|
|
Bulletin from the extraordinary general meeting in SciBase Holding AB (publ) |
|
|
The exercise price for warrants of series TO 3 has been determined |
